Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3818511 A
Publication typeGrant
Publication dateJun 25, 1974
Filing dateNov 17, 1972
Priority dateNov 17, 1972
Publication numberUS 3818511 A, US 3818511A, US-A-3818511, US3818511 A, US3818511A
InventorsS Bazell, E Goldberg, R Ostensen
Original AssigneeMedical Prod Corp
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Medical prosthesis for ducts or conduits
US 3818511 A
Abstract
Medical prosthesis for ducts or conduits and method of manufacture. An exemplary embodiment is an arteriovenous shunt having a cannula terminated in a funnel in which the interior included angle ranges from 15 DEG - 30 DEG . The funnel is of an implantable, resilient silicone rubber into which a woven, flexible Dacron skirt is molded to enable suturing and tissue ingrowth at the anastomotic juncture. The silicone is of a medical type which is body tissue-compatible, and has sufficient elasticity and resilience to permit compliance during pulsatile fluid flow, storage and return of fluid kinetic energy, and accommodation to various sizes of vessels, ducts, or conduits. Actual experimental use shows improved results compared to prior types of tip-type cannulae.
Images(2)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent [191 Goldberg et al.

[ MEDICAL PROSTHESIS FOR DUCTS OR CONDUITS [75] Inventors: Edward M. Goldberg, Glencoe;

Seymour Bazell, Skokie; Ralph G. Ostensen, Morton Grove, all of I11.

[73] Assignee: Medical Products Corporation,

Skokie, Ill.

22 Filed: Nov. 17, 1972 211 Appl. N01: 307,641

[52] US. Cl 3/1, 3/DIG. 1, 128/214 R, 128/334 R, 128/348, 264/257 [51] Int. Cl..... A6lf 1/24, A6lm 5/00, A6lm 25/00 [58] Field of Search 3/1, DIG. 1; 128/214 R, 128/214 B, 348, 334 R, 334 C, l R

[56] References Cited v UNITED STATES PATENTS 3,646,616 3/1972 Keshin 3/1 3,667,069 6/1972 Blackshear et a1. 3/1 3,713,441 1/1973 Thomas 128/214 R FOREIGN PATENTS OR APPLICATIONS 1,546,118 10/1968 France 3/1 OTHER PUBLICATIONS A Large-Vessel Applique A-V Shunt For Hemodial- June 25,1974

Primary Examiner-Richard A. Gaudet Assistant Examiner-Ronald L. Frinks Attorney, Agent, or Firm-Molinare, Allegretti, Newitt & Witcoff 5 7 ABSTRACT Medical prosthesis for ducts or conduits and method of manufacture. An exemplary embodiment is an arteriovenous shunt having a cannula terminated in a funnel in which the interior included angle ranges from 15 The funnel is of an implantable, resilient silicone rubber into which a woven, flexible Dacron skirt is molded to enable suturing and tissue ingrowth at the anastomotic juncture. The silicone is of a medical type which is body tissue-compatible, and has sufficient elasticity and resilience to permit compliance during pulsatile fluid flow, storage and return of fluid kinetic energy, and accommodation to various sizes of vessels, ducts, or conduits. Actual experimental use shows improved results compared to prior types of tip-type cannulae.

9 Claims, 7 Drawing Figures 24(CLOTH SKIRT) 6 (SHANK) (PUMA/5L 7 (CONNECTOR) 2 (cA/v/vuLA) MEDICAL PROSTHESIS FOR DUCTS OR CONDUITS FIELD OF THE INVENTION This invention is directed to an improved prosthesis for access to, and transport of ducted fluids, such as the vascular, lymphatic, reproductive, regulatory (e.g. glandular) or excretory systems, and repair, extension or access to other body ducts or tubes, such as tracheal, esophagogastrointestinal systems and the like. The invention also includes methods of manufacture of the prosthetic devices. More specifically, the invention is directed to a tipless, funnel-terminated, tubular prosthesis in which the interior angle of the funnel ranges from 30, which funnel is molded of high compliance, body tissue-compatible, flexible, resilient silicone rubber, and has molded therein a Dacron skirt for tissue ingrowth at the anastomotic junctions.

BACKGROUND OF THE INVENTION There is a clear need for artificial, implantable duct prosthesis for treatment or cure of various medical conditions in animals and humans. Examples include artificial veins or arteries used in treatment of circulatory conditions. Likewise repair of, or access to the GI. tract may employ artificial ducting. All of such ducting involves the connecting (anastomosing) of the ducts to body tissue, usually the natural duct which is being replaced or repaired, or connection to the organ or organs which communicate with the natural duct. Frequently the artificial duct prosthesis is led extracorporeally for treatment of the ducted fluid and return to the body, e.g. blood for dialysis in cases of kidney failure.

All such artificial duct prostheses pose serious medical problems at their anastomotic juncture within the body, for example juncture necrosis, chronic infection, leakage, thrombosis, stricture and the like. This invention is directed to an improved juncture prosthesis or duct terminus. The discussion which follows will be with reference to an arteriovenous shunt by way of example, but it is to be understood that the funnel prostheses of this invention may be applied to any artificial implantable duct, or to a natural duct that is being anastomosed to a natural or artificial duct, organ or tissue, as the case may be.

In the United States, approximately 50,000 persons each year suffer some degree of renal (kidney) failure. Of this number, fully percent, or 10,000 patients, can be helped by dialyzing the blood to remove the accumulated urea and other metabolic byproducts.

Kolff introduced direct dialysis of arterial blood, thereby employing arteriostatic pressure to assist in the dialysis. Quinten and Scribner developed an arteriovenous shunt system employing a tipped cannula sutured at 90 to an artery, tunneled subcutaneously, exited through the skin, and connected externally to a similar cannula which analogously was sutured to a vein. When hemodialysis was required, the shunt was disconnected externally and the arterial line was connected to the dialysis machine. The return line from the machine was connected to the venous cannula.

Such Quinten-Scribem shunts are often disfiguring and ineffective, complicated by frequency infections and thrombosis. The tips of the Scriber shunts are very inefficient, with significant turbulence, and low flow rates, which contribute to the thrombosis. The cannula tip is attached to the blood vessel by sutures, and causes juncture necrosis and strictures.

Results of using tip-type cannulae were reported by Baillod et al. at the 1969 meeting of the European Dialysis and Transplant Association, reported at Proc. Europ. Dialysis Transplant Assn., 6:65, 1969. 60 patients treated for more than one year exhibited arterial cannula survival of 13.5 months, during which an average of two and one half cannulae were required. Their venous cannulae survived an average of 8 /2 months, with four cannulae required per patient.

Problems with shunts led Brescia and Cimino to the innovation of the internal arteriovenous fistula which remains post-surgically subcutaneous. In this procedure, the side of an artery is sutured to the side of a vein to form a classical, side-by-side, h-shaped shunt. When dialysis is desired the shunt loop is punctured with hypodermic needles attached to the inlet and return lines of the dialysis machine.

However, the Brescia-Cimino internal A-V fistula is not without its serious problems. The use of the fistula requires training and skill in venipuncture, which frequently mitigates against home dialysis by the patient or other unskilled persons. After repeated punctures with large bore needles, hematomas, scarring, induration and false aneurysms-develop.

There is,therefore, a great need for improved juncture prostheses for ducts and conduits of all types, both internal and external shunts to provide for vascular access, and access to the lymphatic system, reproductive system, regulatory system, excretory system. G. I. system and the like or to other organs or implanted prostheses to or from which fluid (gas or liquid) transmittal is desired. The ducts should be readily established and perform continuously as long as needed. They must allow adequate fluid (e.g., blood) flow, be nonthrombogenic and free of infection. They should be easily declottable, and should be large enough to provide adequate fluid volume exit or input.

THE INVENTION OBJECTS It is among the objects of this invention to provide an improved duct juncture prosthesis which overcomes the above-described problems of the prior art tips and achieves the goals set forth for improved medical ducts, e.g., A-V shunts and the like.

It is another object to provide a juncture prosthesis for ducts which has fluid dynamics advantages, and presents improved survival expectancy.

It is another object to provide a funnel juncture prosthesis for ducts which may be used internally or externally, and which may be used for access to any body organ or tissue from any other, or from the exterior, and for transport of any fluid (gas or liquid) which is input, withdrawn, administered or monitored.

It is another object of this invention to provide a funnel juncture for a shunt prosthesis which exhibits low incidence of late failure, thrombosis, provides smooth transition from body organ, duct or tissue to the prosthesis, is simple to declot, has excellent flow rates, an absence of major clinical complications, and exhibits long survival.

Still other objects will be evident from the following summary and detailed description.

SUMMARY Our juncture prosthesis employs a tipless" cannula having a dacron-skirted silicone rubber funnel at an end for transmitting fluids across an anastomotic site. We have discovered that best hemodynamic and medical properties are obtained when the included angle of the funnel ranges from about 30, whether the funneledorifice is anastomosed end-to-end or at an acute angle to a body duct, organ or tissue. The flexibility, resilience and compliance of the silicone rubber is selected to permit sufficient elasticity to be responsive to natural pulsatile flow, and to store and return fluid kinetic energy. The funnel is also sufficiently elastic to be self-compensating within small angles, thus permitting anastomosis to vessels or ducts of varying size. The Dacron skirt permits tissue ingrowth with a pseudoendothelium and a fibrous adventitia which prevents buildup of fibrin at the anastomotic juncture. The juncture funnel prostheses of this invention are applicable to internal A.V. fistulae, arterialized vein shunts, external shunts, or to any situation where fluid (gas or liquid) is to be transferred to or from any body duct, organ or tissue to another, or to or from the exterior. Improved results are demonstrated by the prostheses of this invention.

BRIEF DESCRIPTION OF THE DRAWINGS The following detailed description makes reference to the FIGURES in which:

FIG. 1 illustrates in sectional view the funnel assembly for a cannula prosthesis in accordance with this invention;

FIG. 2 illustrates in sectional view a molding apparatus employed in the method of manufacture of the prostheses of this invention;

FIG. 3 shows in perspective a funnel assembly in accordance with this invention particularly useful for end-to-end anastomosis;

FIG. 4 shows in perspective a funnel assembly in accordance with this invention for acute angle anastomosis;

FIG. 5 shows an exemplary prosthesis of this invention in use; and

FIGS. 6a and 6b compare flow with the funnel prosthesis of this invention to prior art tipped" cannulae.

DETAILED DESCRIPTION Referring to FIGS. 1, 3 and 4, the prosthesis of this invention comprises a funnel assembly I mounted on a cannula tube 2. The funnel assembly in turn includes a cloth skirt 3, typically a sterile polyester (Dacron) cloth, for example, one about 0.007 inch thick, embedded in the walls of the funnel mouth portion 4 as at 5. The Dacron cloth may be flat or formed into a conical shape. Shank portion 6 connects the funnel mouth portion 4 with connector portion 7, into which is seated a cannula 2. The cannula 2 may be secured into connector portion 7 with cannula tip 8 abutting against shoulder 9 in a manner to provide a smooth interior passage at 10. We prefer to use a silicone cement 11 to join the tube 2 to the funnel assembly. The funnel walls may be tapered so that the mouth edge 4 is thinner and more flexible than the shank end portion 6. This flexibility permits a range of fit for various sized ducts or blood vessels, and compensates for pulsatile fluid flow by storage and return of kinetic energy.

Critical to our invention is the fact that the included angle 6, defined as the angle lying between the inner surfaces l2, 12' of the funnel mouth, is in the range of about 15 30. This provides a smooth transition of flow of fluids, e.g., blood, lymph, urine, oxygen or the like in either direction through the tipless cannula prosthesis, and improves system survival. In addition, the entrance energy loss using our prosthesis is tenfold less than a constant diameter orifice anastomosed end-toend to a duct. In such constant diameter juncture, the entrance loss is 0.5 (V /2g), where V is flow velocity and g is gravity. In our tipless funnel juncture prosthesis, the entrance loss is one tenth, that is, 0.05 (V /2g) for the same flow velocity.

In addition to the end-to-end anastomosis, we have found that the same type of funnel transition provided for by our tipless funnel cannulae is beneficial when anastomosing vessels end-to-end to ducts or cannulae. As seen in FIG. 6a in the prior art techniques employing tip-type cannulae 28, there is almost always a stric ture or sudden reduction 29 of the internal diameter of the vessel which is anastomosed to the body vessel or duct 30. This abrupt narrowing of the diameter results in frictional energy losses and boundary layer separation 31 contributing to hemolysis and the formation of thrombi whether the flow is converging or diverging. In addition, there is a pressure drop with up to 50 percent velocity head loss, occasioned by the use of such tiptype cannula. In contrast, as seen in FIG. 6b, end-toend anastomosis using the tipless funnel-type cannula l of this invention for either converging or diverging flow affords a smooth translation and flow 32, improves system survival, promotes more effective declotting, helps eliminate the buildup of fibrin at the junction of the cannula and vessel, and generally exhibits an absence of major clinical complications. We have been able to observe cannula survival of over two years, using the cannula of this invention.

The funnel juncture prosthesis, anastomosed to the arterial limb ofa fistula or any afferent flow duct, is the converging channel with a short graduated contraction of diameter. The converging channel or nozzle" refers to a channel system in which the velocity of the fluid is increased and the pressure is reduced. The fluid is accelerated in the converging channel and some pressure head is converted into velocity head. In general, this conversion is a stable process and can be made with few losses.

The prosthesis anastomosed to the venous limb of the fistula or any efferent flow duct is the diverging channel with a short gradual enlargement of diameter. The diverging channel or diffuser refers to a channel in which the velocity of fluid is decreased and the pressure is increased. The flow involves a conversion of velocity head to pressure head. As the fluid moves down stream, a greater boundary layer forms and grows in thickness. The fluid may not fill the channel completely, but separates by breaking away from the walls. This results in eddy formation and dissipation of energy by turbulent mixing. Flow in a diverging channel is more troublesome than flow in a converging nozzle and can be an unstable inefficient process.

In evaluating the efficiency of a diverging channel, it is necessary to consider the velocity variations across the channel. The diverging channel efficiency can be considered as a function of the total included angle of divergence (0). Theta represents a particular expansion ratio or ratio of final area to initial area. The efficiency is high (75 90 percent) in the region between 0 and 30. Beyond about 30, the efficiency decreases with an increase in the included angle.

We further have improved the system by the provision of flexibility and compliance so that in pulsatile flow, the juncture expands upon systoly storing kinetic energy, and delivers the energy to the fluid on diastoly.

Turning now to FIG. 2, this figure illustrates the method of construction of the funnel assembly of our invention. Mold 13 comprises a skirt holder plate 16 and body-forming plate 17. In manufacture, a core, ring or washer of Dacron cloth, a medical grade such as US. Catheter& Instrument Corp. No. 6103, is centered over the central aperture 19 in the body-forming plate 17. The Dacron cloth may be of any type which has sufficiently large mesh to permit complete inpregnation of the silicone rubber around the fibers. Thereafter, the skirt holder plate 16 is placed thereover to securely retain the Dacron skirt in position during molding. The skirt holder is shown as flat, but may be conical. Centering pins l8, 18 are inserted to secure the mold parts together, and the mold is then positioned on the bottom plate of the molding press. Centering pins 18 and 18 extend into recesses 20, 20 in the bottom plate of the press for proper centering of the shoulder-forming projection 21 in the mold aperture. A tubular slug of vinyl type silicone rubber molding compound, such as a Dow-Corning *Silastic" brand rubber MDX-445l2, is dropped into the mold aperture 19, and top press plate 14 is lowered into position to compression-mold the silicone rubber, for ten minutes at 260F. In the alternative, 21 fluorosilicone may be used; this type silicone rubber exhibits lesser clotting characteristics under dynamic flow conditions. The mold pin 22 projecting from the top press plate 14 forces the gum-like silicone rubber into the mold cavity. Optionally, the amount of the silicone rubber slug may be chosen so that there may be very small excess of the silicone rubber which extrudes into the cloth skirt beyond the outward edge of the funnel mount portion 4. This is best illustrated in FIG. 1 as zone 23. The extrusion of this silicone provides a zone for anchoring the sutures when anastomising the funnel mouth to the body vessel or duct. The funnel mouth walls 12, 12 are thus free of turbulence-causing sutures, yet there is a sufficient feather edge of silastic-impregnated Dacron to provide for proper suture anchorage while at the same time sealing against fluid loss. The outer edge of the Dacron skirt 24 is open mesh which providesfor tissue ingrowth. The excess skirt may be trimmed as desired to fit any given duct size. For a tipless funnel juncture prosthesis of 0.125 inch ID. and a funnel mouth opening of 0.250 inches, we employ approximately 0.1 gram of a silicone rubber slug for the molding.

After the compressionmolding for ten minutes at 260F., the funnel assembly part is extracted from the mold and inspected. Thereafter, the molded funnel assembly part is post-cured for four hours at 350F. All flashing is trimmed from the part, and after final inspection and washing, it is ready for assembly on a cannula tube. In assembling the cannula tube, a clean, transversely cut end of a cannula is painted on its exterior surface with a medical grade silicone rubber adhesive, such as Dow-Corning medical grade Silastic brand adhesive Type A, and inserted into the connector portion of the funnel assembly. Excess may build up and form a smooth transition shoulder, as 11, seen in FIG. 1. The final tipless funnel cannula prosthesis is best seen in FIGS. 3 and 4. FIG. 3 illustrates a prosthesis either for end-to-end anastomosis with a body vessel, duct, tissue or organ, or for end-to-side anastomosis. FIG. 4 shows a tipless funnel cannula prosthesis having an oval or eliptical-shaped funnel mouth which is oriented at an angle to the longitudinal axis of the shank and connector portions. This oblique funnel is particularly adapted for acute angle end-to-side anastomosis to body vessels, ducts, tissues or organs.

The method of employing the tipless funnel cannula of this invention may be seen with reference to FIG. 5. This description is in reference to providing vascular access to an arterialized vein although it should be understood that vascular access is merely exemplary of the more general use of the cannula of this invention. FIG. 5 shows the use, in a 2-step procedure, of our tipless funnel cannula where external access is required.

A suitably dilated arterialized vein 33 is selected for cannulation. This vessel is severed transversely at 34 and each end 35, 36 directly anastomosed to a tipless, funnel-shaped skirted cannula 37, 38 of this invention. The cannulae may be buried in subcutaneous tunnels 39 with open cell silicone rubber cuffs for fixation and seal. The exterior loop 40 of the cannula tube 2 may be adapted to come apart at collar 25 for attachment of the outlet segment 26 and inlet segment 27 to the inlet tube 41 and outlet tube 42 of the dialyzer 43.

Optionally, a direct fistula can be created by directly anastomising a cannula terminated at each end with a funnel prosthesis of this invention and utilizing a vein graft for juncture to the small artery. First, one end of a vein graft is anastomosed to an artery and the other end anastomised to the mouth of the funnel prosthesisterminated cannula. A vein is then selected for return flow to the heart and the distal branch of this vein anastomised to the funnel prosthesis at the other end of the cannula.

It is also possible to make a vein-to-vein shunt, as in a porto-canal shunt to reduce portal hypertension. In the same manner an artery-to-artery shunt can be performed (artery bypass). As above, for access to small vessels, we use a vein graft anastomosed to a funnel mouth, and for large vessels, we can directly anastomose our funnel juncture prosthesis thereto.

Fourteen or our new external fistula systems using tipless, funnel-skirted prostheses of this invention have been created for external circulatory access useful in chronic hemodialysis. The treatment periods range from 2 to 34 months. In all 14 patients flow exceeded 300 ml/min. Taken as a whole 13 of 14 systems have survived to date, representing an experience of 213 months with a mean survival of 15.2 months. The 14 arterial prostheses had a mean survival of 15.0 months; the 13 venous prostheses had a mean survival of [2.4 months. All arterial and venous prosthesis replacements have not been included in the above analysis. Expression of data in this manner, however, is unsatisfactory. Any series, with a number of patients having a short period of observation will, when calculated in this manner, result in spuriously low survival times. Thus, the survival times will actually be greater than the number of months calculated in the above manner.

If survival data are computed only from patients observed for more than 12 months, (including all failures even under 12 months), the recalculated mean survival times are as follows: for an arterial prosthesis 19.3 months, and for a venous prosthesis 15 months. This compares to 13.5 months (arterial) and 8.5 months (venous) for tipped cannulae of the prior art.

A more meaningful representation of circulatory access survival data would be to express it in terms of estimated survival curves calculated by standard life table techniques described by Merrell and Shulman Determination of Prognosis of Chronic Disease Illustrated by Systemic Lupus Erythematosus, .1. Chronic Dis. 1, (1955). The logarithm of the percent surviving is plotted against the duration in months. These curves are of course provisional since the numbers are small. They show the expected survival of an arterial prosthesis is 80 percent, and for the venous prosthesis about 50 percent under these circumstances.

It is to be understood that various modifications within the scope of this invention can be made by one of ordinary skill in the art without departing from the spirit thereof. We therefore wish our invention to be defined by the scope of the appended claims as broadly as the prior will permit, and in view of this specification if need be.

We claim:

1. A medical prosthesis for providing vascular access to an arterialized vein which comprises:

a. a cannula;

b. a funnel assembly secured to an end of said cannula, said funnel assembly comprising: i. a connector portion connected to said cannula;

ii. a funnel portion with walls having an included interior angle ranging from about 15 to 30, said walls tapering to a smaller thickness at the mouth 8 of the funnel;

c. said funnel assembly being a tissue compatible, silicone rubber with sufficient flexibility and compliance so that in pulsatile flow, the funnel walls expand upon systole and deliver energy during diastole;

d. a flexible fabric skirt embedded in the walls of said funnel portion and extending outward from the edges of the funnel mouth a distance sufficient to provide for tissue growth therein and to connect the prosthesis through the skirt to a vein or artery.

2. A prosthesis as in claim 1 wherein a plane defined by the distal edge of said funnel mouth portion is ori ented at an angle to the longitudinal axis of said connector portion to provide an elliptical funnel mouth.

3. A prosthesis as in claim 1 wherein a plane defined by the distal edge of said funnel mouth is oriented at substantially a angle to the longitudinal axis of said connector portion.

4. A prosthesis as in claim 1 where a portion of said fabric adjacent said funnel mouth is impregnated with silicone rubber to provide suture anchorage for anastomosis.

5. A prosthesis as in claim 1 wherein said connector portion comprises a collar having an inner diameter suitable for fitting over said cannula and a shoulder to abut the end of said cannula,

6. A prosthesis as in claim 1 wherein said cannula is a body tissue compatible tube.

7. A prosthesis as in claim 6 wherein each end of said cannula has a funnel assembly secured thereto.

8. A prosthesis as in claim 6 wherein said cannula is silicone rubber.

9. A prosthesis as in claim 1 wherein said silicone rubber is a fluorosilicone rubber.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3646616 *Jul 23, 1969Mar 7, 1972Jesse G KeshinProsthesis for implanting around a body duct such as the urethra and method of treating urinary incontinence
US3667069 *Mar 27, 1970Jun 6, 1972Univ MinnesotaJet pump cardiac replacement and assist device and method of at least partially replacing a disabled right heart
US3713441 *Oct 22, 1970Jan 30, 1973Battelle Development CorpMethod of using an artery vein shunt applique
FR1546118A * Title not available
Non-Patent Citations
Reference
1 *A Large Vessel Applique A V Shunt For Hemodialysis by G. I. Thomas, Transactions Amer. Soc. Artif. Internal Organs, Vol. 15, 1969, pages 288 292.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3882862 *Jan 11, 1974May 13, 1975Olga BerendArteriovenous shunt
US4217664 *Feb 2, 1979Aug 19, 1980Faso Joseph MProsthesis and method for creating a stoma
US4318401 *Apr 24, 1980Mar 9, 1982President And Fellows Of Harvard CollegePercutaneous vascular access portal and catheter
US4405305 *Feb 17, 1981Sep 20, 1983University Of Utah Research FoundationSubcutaneous peritoneal injection catheter
US4557724 *Aug 12, 1983Dec 10, 1985University Of Utah Research FoundationApparatus and methods for minimizing cellular adhesion on peritoneal injection catheters
US4559033 *Aug 12, 1983Dec 17, 1985University Of Utah Research FoundationApparatus and methods for minimizing peritoneal injection catheter obstruction
US4693704 *Oct 12, 1983Sep 15, 1987Sumitomo Bakelite Company LimitedCervical canal catheter
US4719916 *Sep 19, 1986Jan 19, 1988Biagio RavoFor attachment in the lumen of a resectioned intestine
US4854316 *Oct 3, 1986Aug 8, 1989Davis Emsley AApparatus and method for repairing and preventing para-stomal hernias
US4905693 *Nov 16, 1988Mar 6, 1990Biagio RavoSurgical method for using an intraintestinal bypass graft
US5084064 *Jun 15, 1989Jan 28, 1992Abiomed Cardiovascular, Inc.Surgical cuff
US5234006 *Jan 18, 1991Aug 10, 1993Eaton Alexander MAdjustable sutures and method of using the same
US5236446 *Mar 2, 1989Aug 17, 1993Dumon Jean FrancoisTubular endoprosthesis for anatomical conduits
US5389088 *Nov 13, 1992Feb 14, 1995Hageman; Marinus J.Grommet
US5413597 *Apr 15, 1993May 9, 1995Krajicek; MilanThree-layer vascular prostheses
US5425739 *Dec 17, 1992Jun 20, 1995Avatar Design And Development, Inc.Anastomosis stent and stent selection system
US5425761 *Nov 21, 1990Jun 20, 1995Lundgren; DanImplant with a through passage
US5456712 *Oct 18, 1993Oct 10, 1995Maginot; Thomas J.Graft and stent assembly
US5480434 *Jul 13, 1993Jan 2, 1996The University Of MiamiMethod and device for connecting biological duct to a prosthesis
US5667486 *Apr 26, 1994Sep 16, 1997Ams Medinvent, S.A.Prostatic stent
US5676696 *May 3, 1996Oct 14, 1997Intervascular, Inc.Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5683449 *Feb 24, 1995Nov 4, 1997Marcade; Jean PaulModular bifurcated intraluminal grafts and methods for delivering and assembling same
US5693088 *Jun 7, 1995Dec 2, 1997Lazarus; Harrison M.Intraluminal vascular graft
US5911757 *Jun 7, 1995Jun 15, 1999Seare, Jr.; William J.Methods and apparatus for transcutaneous access
US5922019 *Dec 29, 1995Jul 13, 1999Schneider (Europe) A.G.For use in a body passageway
US5934286 *Jun 4, 1998Aug 10, 1999Maginot Vascular SystemsBypass grafting method which uses a number of balloon catheters to inhibit blood flow to an anastomosis site
US5979455 *May 5, 1998Nov 9, 1999Maginot Vascular SystemsMethod for directing blood flow in the body of a patient with a graft and stent assembly
US5989287 *May 6, 1998Nov 23, 1999Av Healing LlcVascular graft assemblies and methods for implanting same
US6022312 *May 1, 1996Feb 8, 2000Chaussy; ChristianEndosphincter, set for releasable closure of the urethra and method for introduction of an endosphincter into the urethra
US6086553 *Jul 1, 1999Jul 11, 2000Akbik; Mohamad J.Arteriovenous shunt
US6261255 *Nov 6, 1998Jul 17, 2001Ronald Jay MullisTubing for arteriovenous fistula composed of polytetrafluoroethylene, silicone or fluorosilicone; clogging and occlusion resistant
US6283992Jul 9, 1999Sep 4, 2001Schneider (Europe) GmbhConical stent
US6338724 *Mar 29, 1999Jan 15, 2002Christos D. DossaArterio-venous interconnection
US6355020 *Oct 29, 1999Mar 12, 2002Gerald G. BousquetTranscutaneous access device
US6371981Nov 2, 1999Apr 16, 2002Av Healing LlcVascular graft assemblies and methods for implanting same
US6395019Aug 14, 1998May 28, 2002Trivascular, Inc.Endovascular graft
US6401721Nov 8, 1999Jun 11, 2002Cardiothoracic Systems, Inc.Endoscopic bypass grafting method utilizing an inguinal approach
US6533810Sep 4, 2001Mar 18, 2003Schneider (Europe) AgConical stent
US6582409 *Jan 24, 2000Jun 24, 2003Graftcath, Inc.Hemodialysis and vascular access systems
US6585762Nov 1, 2000Jul 1, 2003Paul StanishArteriovenous grafts and methods of implanting the same
US6589278May 15, 1998Jul 8, 2003Impra, Inc.Vascular prosthesis
US6599313Dec 30, 1999Jul 29, 2003Cardiothoracic Systems, Inc.Extravascular bypass grafting method utilizing an intravascular approach
US6746480 *Jul 3, 2001Jun 8, 2004Bard Peripheral Vascular, Inc.Flanged graft for end-to-side anastomosis
US6818015Mar 3, 2003Nov 16, 2004Schneider (Europe) GmbhConical stent
US6821295 *Jun 26, 2000Nov 23, 2004Thoratec CorporationFlared coronary artery bypass grafts
US7044962Jun 25, 2002May 16, 2006Scimed Life Systems, Inc.Implantable prosthesis with displaceable skirt
US7081129Apr 24, 2002Jul 25, 2006Boston Scientific Santa Rosa Corp.Endovascular graft
US7147660Dec 20, 2002Dec 12, 2006Boston Scientific Santa Rosa Corp.Advanced endovascular graft
US7147661Dec 20, 2001Dec 12, 2006Boston Scientific Santa Rosa Corp.Radially expandable stent
US7195646 *Oct 28, 2002Mar 27, 2007Oded NahleiliPolymeric stent useful for the treatment of the salivary gland ducts and method for using the same
US7252680Apr 5, 2002Aug 7, 2007Alveolus, Inc.Removable essentially cylindrical implants
US7390317Dec 2, 2002Jun 24, 2008Applied Medical Resources CorporationUniversal access seal
US7507258Mar 5, 2007Mar 24, 2009Oded NahleiliPolymeric stent useful for the treatment of the salivary gland ducts and method for using the same
US7527644Nov 5, 2002May 5, 2009Alveolus Inc.Stent with geometry determinated functionality and method of making the same
US7547321Jul 5, 2002Jun 16, 2009Alveolus Inc.Removable stent and method of using the same
US7553316May 10, 2004Jun 30, 2009Bard Peripheral Vascular, Inc.Flanged graft for end-to-side anastomosis
US7597697 *Jul 11, 2001Oct 6, 2009Boston Scientific Scimed, Inc.Bypass grafting method
US7615071Mar 28, 2006Nov 10, 2009Trivascular2, Inc.Endovascular graft
US7637942Sep 24, 2003Dec 29, 2009Merit Medical Systems, Inc.Coated stent with geometry determinated functionality and method of making the same
US7686845Oct 24, 2006Mar 30, 2010Devax, Inc.Noncylindrical stent deployment system for treating vascular bifurcations
US7731654May 13, 2005Jun 8, 2010Merit Medical Systems, Inc.Delivery device with viewing window and associated method
US7753946 *Feb 9, 2007Jul 13, 2010Boston Scientific Scimed, Inc.Bypass grafting system and apparatus
US7762977Aug 31, 2005Jul 27, 2010Hemosphere, Inc.Device and method for vascular access
US7766954Jan 17, 2006Aug 3, 2010Trivascular2, Inc.Advanced endovascular graft
US7780720 *Oct 24, 2003Aug 24, 2010Scimed Life Systems, Inc.Bifurcated endoluminal prosthesis
US7803178Jan 30, 2004Sep 28, 2010Trivascular, Inc.Inflatable porous implants and methods for drug delivery
US7875068Sep 30, 2003Jan 25, 2011Merit Medical Systems, Inc.Removable biliary stent
US7887579Sep 12, 2007Feb 15, 2011Merit Medical Systems, Inc.Active stent
US7896846Nov 20, 2003Mar 1, 2011Tyco Healthcare Group LpTrocar seal system
US7901449Jul 18, 2007Mar 8, 2011Scimed Life Systems, Inc.Bifurcated endoluminal prosthesis
US7942919Feb 23, 2004May 17, 2011Scimed Life Systems, Inc.Bifurcated endoluminal prosthesis
US7959671Nov 20, 2003Jun 14, 2011Merit Medical Systems, Inc.Differential covering and coating methods
US7993386Apr 6, 2006Aug 9, 2011Boston Scientific Scimed, Inc.Implantable prosthesis with displaceable skirt
US8002934Aug 25, 2009Aug 23, 2011Tyco Healthcare Group LpTrocar seal system
US8047986 *Jun 29, 2007Nov 1, 2011Applied Medical Technology, Inc.Molded and undivided medical penetrating device
US8066755Sep 26, 2007Nov 29, 2011Trivascular, Inc.System and method of pivoted stent deployment
US8079973Mar 3, 2009Dec 20, 2011Hemosphere Inc.Vascular access system
US8079986Nov 30, 2007Dec 20, 2011Applied Medical Resources CorporationUniversal access seal
US8083789Nov 16, 2007Dec 27, 2011Trivascular, Inc.Securement assembly and method for expandable endovascular device
US8096966 *Jun 21, 2010Jan 17, 2012Gi Dynamics, Inc.Eversion resistant sleeves
US8109911Nov 30, 2007Feb 7, 2012Applied Medical Resources CorporationUniversal access seal
US8118767Sep 2, 2008Feb 21, 2012Laufer Michael DGastrointestinal implant and methods for use
US8192405Aug 25, 2009Jun 5, 2012Tyco Healthcare Group LpTrocar seal system
US8206436Nov 11, 2009Jun 26, 2012Merit Medical Systems, Inc.Coated stent with geometry determinated functionality and method of making the same
US8226701Sep 26, 2007Jul 24, 2012Trivascular, Inc.Stent and delivery system for deployment thereof
US8231667May 9, 2005Jul 31, 2012Jacques SéguinEndoprosthesis for vascular bifurcation
US8236041Oct 29, 2004Aug 7, 2012Biosensors International Group, Ltd.Noncylindrical stent deployment system for treating vascular bifurcations
US8267898Oct 5, 2010Sep 18, 2012Tyco Healthcare Group LpTrocar seal system
US8267989Aug 20, 2010Sep 18, 2012Trivascular, Inc.Inflatable porous implants and methods for drug delivery
US8282591Mar 29, 2004Oct 9, 2012Iftikhar KhanHybrid arteriovenous shunt
US8328861Nov 16, 2007Dec 11, 2012Trivascular, Inc.Delivery system and method for bifurcated graft
US8361136Sep 25, 2009Jan 29, 2013Trivascular, Inc.Endovascular graft
US8366651Aug 4, 2008Feb 5, 2013Bioconnect Systems, Inc.Implantable flow connector
US8376981Dec 22, 2009Feb 19, 2013Michael D. LauferGastrointestinal implant and methods for use
US8382664Oct 27, 2011Feb 26, 2013Applied Medical Technology, Inc.Molded and undivided medical penetrating device
US8603157Jun 22, 2007Dec 10, 2013Biosensors International Group, Ltd.Endoprosthesis deployment methods for treating vascular bifurcations
US8663309Sep 26, 2007Mar 4, 2014Trivascular, Inc.Asymmetric stent apparatus and method
US8690815Jul 6, 2010Apr 8, 2014Hemosphere, Inc.Device and method for vascular access
US8690816 *Aug 4, 2008Apr 8, 2014Bioconnect Systems, Inc.Implantable flow connector
US8702657Feb 23, 2012Apr 22, 2014Covidien LpTrocar seal system
US8709069Apr 21, 2006Apr 29, 2014C. R. Bard, Inc.Flanged graft with trim lines
US8728143Nov 11, 2002May 20, 2014Biosensors International Group, Ltd.Endoprosthesis deployment system for treating vascular bifurcations
US8801769Jan 9, 2013Aug 12, 2014Trivascular, Inc.Endovascular graft
US8821507 *Jul 6, 2007Sep 2, 2014Howmedica Osteonics Corp.Augmentation delivery device
US20040064181 *Jun 25, 2003Apr 1, 2004Impra, Inc., A Subsidiary Of C.R. Bard, Inc.Vascular prosthesis
US20100130995 *Nov 25, 2009May 27, 2010Phraxis Inc.Anastomotic connector
US20100312163 *Jan 28, 2009Dec 9, 2010Peter ForsellImplantable fluid movement device
US20100312164 *Jan 28, 2009Dec 9, 2010Peter ForsellImplantable drainage device
US20110184329 *Jan 22, 2010Jul 28, 2011Valentin KramerComposite Arterial-Venous Shunt System
USRE41448Aug 15, 2002Jul 20, 2010Hemosphere, Inc.Squitieri hemodialysis and vascular access systems
USRE44639Jan 15, 2010Dec 10, 2013Hemosphere, Inc.Hemodialysis and vascular access system
WO1991019522A1 *Jun 12, 1991Dec 15, 1991Baxter IntNeedle assembly for reduced coagulation
WO1998044869A1 *Apr 6, 1998Oct 15, 1998Univ BelfastHaemodynamic control device
WO1998050093A1 *May 1, 1998Nov 12, 1998United States Surgical CorpTrocar seal system
WO2002054987A2 *Dec 20, 2001Jul 18, 2002Sulzer Carbomedics IncProsthetic graft device with ventricular apex attachment apparatus
WO2007011689A2 *Jul 14, 2006Jan 25, 2007Brigham & Womens HospitalSterile access conduit
WO2008014752A1 *Jul 20, 2007Feb 7, 2008Michael HeiseTubular vascular transplant
WO2012018917A1 *Aug 3, 2011Feb 9, 2012World Heart CorporationConformal cannula device and related methods
WO2012122220A1 *Mar 7, 2012Sep 13, 2012W.L. Gore & Associates, Inc.Medical device for use with a stoma
Classifications
U.S. Classification623/1.31, 606/153, 264/257, 604/175, 623/9, 623/23.64
International ClassificationA61M39/10, A61M1/36, A61B17/11
Cooperative ClassificationA61M1/3655, A61M2001/3659, A61B2017/1139
European ClassificationA61M1/36C7A